Biogen (BIIB)
(Delayed Data from NSDQ)
$189.07 USD
-5.05 (-2.60%)
Updated Sep 25, 2024 03:59 PM ET
After-Market: $189.70 +0.63 (0.33%) 6:46 PM ET
3-Hold of 5 3
B Value D Growth F Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $3.80 | -11.11% |
Earnings Summary
For their last quarter, Biogen (BIIB) reported earnings of $5.28 per share, beating the Zacks Consensus Estimate of $4.00 per share. This reflects a positive earnings surprise of 32.00%. Look out for BIIB's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of $3.80 per share, reflecting a year-over-year decrease of 12.84%.
Earnings History
Price & Consensus
Zacks News for BIIB
Eli Lilly Secures Approval for Alzheimer's Drug Kisunla in Japan
BIIB: What are Zacks experts saying now?
Zacks Private Portfolio Services